Michael J. Farrell, Director, Chairman and Chief Executive Officer, on August 07, 2026, sold 4,991 shares in Resmed (RMD) for $1,026,596. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,346 common shares of the company, with 466,256 shares held directly and 2,090 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/943819/000094381926000043/xslF345X05/form4.xml